---
figid: PMC5378352__pone.0174555.g006
figlink: /pmc/articles/PMC5378352/figure/pone.0174555.g006/
number: Fig 6
caption: ATRA treatment induces cell apoptosis by controlling cell death regulators
  (survivin and bcl-2) via RAR-β, inhibits VEGF-VEGFR signaling pathway via RAR-α,
  and regulates the expression of angiogenic factors (Ang-1, Ang-2 and Tie-2) and
  angiogenesis. In vivo, ATRA suppressed tumor growth and metastasis. Previously reports
  and the current study demonstrate that ATRA inhibits cell viability, angiogenesis
  and metastasis of esophageal cancer cells in vitro and in vivo.
pmcid: PMC5378352
papertitle: All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits
  angiogenesis and metastasis in esophageal squamous cell carcinoma.
reftext: Na Li, et al. PLoS One. 2017;12(4):e0174555.
pmc_ranked_result_index: '18668'
pathway_score: 0.8281479
filename: pone.0174555.g006.jpg
figtitle: All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits
  angiogenesis and metastasis in esophageal squamous cell carcinoma
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5378352__pone.0174555.g006.html
  '@type': Dataset
  description: ATRA treatment induces cell apoptosis by controlling cell death regulators
    (survivin and bcl-2) via RAR-β, inhibits VEGF-VEGFR signaling pathway via RAR-α,
    and regulates the expression of angiogenic factors (Ang-1, Ang-2 and Tie-2) and
    angiogenesis. In vivo, ATRA suppressed tumor growth and metastasis. Previously
    reports and the current study demonstrate that ATRA inhibits cell viability, angiogenesis
    and metastasis of esophageal cancer cells in vitro and in vivo.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL2
  - KDR
  - VEGFC
  - VEGFB
  - VEGFD
  - FLT1
  - VEGFA
  - RARA
  - RARB
  - BIRC5
  - TEK
  - PGF
genes:
- word: bcl-2)
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: KDR)
  symbol: KDR
  source: hgnc_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: (Flt-1
  symbol: FLT1
  source: hgnc_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: RAR-a
  symbol: RARA
  source: hgnc_symbol
  hgnc_symbol: RARA
  entrez: '5914'
- word: RAR-B
  symbol: RARB
  source: hgnc_symbol
  hgnc_symbol: RARB
  entrez: '5915'
- word: (survivin,bcl-2)
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: Tie-2
  symbol: TIE-2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
chemicals: []
diseases: []
---
